{"transactions":[{"id":710707,"issuer":{"id":4040,"kind":"organization","name":"Indivior Pharmaceuticals, Inc."},"owners":[{"id":30846,"kind":"person","name":"Heidbreder Christian","position":1,"cik":"0002014639","reported_name":"Heidbreder Christian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2026-07-13T20:31:42.000Z","date":"2026-07-10","kind":"sale","planned":true,"acquired":false,"shares":18586,"price":41.14,"value":764628.04,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2026."}],"balance_after":209337,"source":{"system":"sec-edgar","filing":"0002014639-26-000011","document":"wk-form4_1783974699.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2014639/000201463926000011/wk-form4_1783974699.xml","form_type":"4"}},{"id":740239,"issuer":{"id":4040,"kind":"organization","name":"Indivior Pharmaceuticals, Inc."},"owners":[{"id":30846,"kind":"person","name":"Heidbreder Christian","position":1,"cik":"0002014639","reported_name":"Heidbreder Christian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2026-06-12T20:10:12.000Z","date":"2026-06-11","kind":"sale","planned":true,"acquired":false,"shares":18586,"price":38.06,"value":707383.16,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2026."}],"balance_after":227923,"source":{"system":"sec-edgar","filing":"0002014639-26-000009","document":"wk-form4_1781295005.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2014639/000201463926000009/wk-form4_1781295005.xml","form_type":"4"}},{"id":858956,"issuer":{"id":4040,"kind":"organization","name":"Indivior Pharmaceuticals, Inc."},"owners":[{"id":30846,"kind":"person","name":"Heidbreder Christian","position":1,"cik":"0002014639","reported_name":"Heidbreder Christian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Performance Stock Units","published_at":"2026-03-05T20:59:02.000Z","date":"2026-03-03","kind":"exercise","planned":false,"acquired":false,"shares":132565,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each performance stock unit represents a contingent right to receive one share of the Issuer's common stock."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each performance stock unit represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Represents the vesting of performance stock units upon the determination that the performance conditions were met at 76.6% with respect to the performance stock units granted to the Reporting\nPerson on March 3, 2023, of which 101,544 shares vested out of the 132,565 target amount."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Represents the vesting of performance stock units upon the determination that the performance conditions were met at 76.6% with respect to the performance stock units granted to the Reporting\nPerson on March 3, 2023, of which 101,544 shares vested out of the 132,565 target amount."}],"balance_after":0,"derivative":{"exercise_price":0,"exercise_date":"2026-03-03","underlying":"Common Stock","underlying_shares":132565},"source":{"system":"sec-edgar","filing":"0002014639-26-000006","document":"wk-form4_1772744339.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/2014639/000201463926000006/wk-form4_1772744339.xml","form_type":"4"}},{"id":858955,"issuer":{"id":4040,"kind":"organization","name":"Indivior Pharmaceuticals, Inc."},"owners":[{"id":30846,"kind":"person","name":"Heidbreder Christian","position":1,"cik":"0002014639","reported_name":"Heidbreder Christian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2026-03-05T20:59:02.000Z","date":"2026-03-03","kind":"tax_withholding","planned":false,"acquired":false,"shares":45797,"price":31.98,"value":1464588.06,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Shares used to satisfy tax withholding obligations associated with the vesting of performance stock units on March 3, 2026."}],"balance_after":246509,"source":{"system":"sec-edgar","filing":"0002014639-26-000006","document":"wk-form4_1772744339.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2014639/000201463926000006/wk-form4_1772744339.xml","form_type":"4"}},{"id":858954,"issuer":{"id":4040,"kind":"organization","name":"Indivior Pharmaceuticals, Inc."},"owners":[{"id":30846,"kind":"person","name":"Heidbreder Christian","position":1,"cik":"0002014639","reported_name":"Heidbreder Christian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2026-03-05T20:59:02.000Z","date":"2026-03-03","kind":"exercise","planned":false,"acquired":true,"shares":101544,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the vesting of performance stock units upon the determination that the performance conditions were met at 76.6% with respect to the performance stock units granted to the Reporting\nPerson on March 3, 2023, of which 101,544 shares vested out of the 132,565 target amount."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each performance stock unit represents a contingent right to receive one share of the Issuer's common stock."}],"balance_after":292306,"source":{"system":"sec-edgar","filing":"0002014639-26-000006","document":"wk-form4_1772744339.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2014639/000201463926000006/wk-form4_1772744339.xml","form_type":"4"}},{"id":907848,"issuer":{"id":4040,"kind":"organization","name":"Indivior Pharmaceuticals, Inc."},"owners":[{"id":30846,"kind":"person","name":"Heidbreder Christian","position":1,"cik":"0002014639","reported_name":"Heidbreder Christian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Performance Stock Units","published_at":"2026-02-12T21:04:42.000Z","date":"2026-02-09","kind":"grant","planned":false,"acquired":true,"shares":132565,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On March 3, 2023, the Reporting Person was granted a conditional award for 132,565 shares, subject to satisfaction of performance conditions, which were certified on February 9, 2026. The award vests, subject to continued employment conditions, on March 3, 2026."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"On March 3, 2023, the Reporting Person was granted a conditional award for 132,565 shares, subject to satisfaction of performance conditions, which were certified on February 9, 2026. The award vests, subject to continued employment conditions, on March 3, 2026."}],"balance_after":132565,"derivative":{"exercise_price":0,"exercise_date":"2026-03-03","underlying":"Common Stock","underlying_shares":132565},"source":{"system":"sec-edgar","filing":"0002014639-26-000004","document":"wk-form4_1770930279.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2014639/000201463926000004/wk-form4_1770930279.xml","form_type":"4"}},{"id":907847,"issuer":{"id":4040,"kind":"organization","name":"Indivior Pharmaceuticals, Inc."},"owners":[{"id":30846,"kind":"person","name":"Heidbreder Christian","position":1,"cik":"0002014639","reported_name":"Heidbreder Christian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2026-02-12T21:04:42.000Z","date":"2026-02-10","kind":"grant","planned":false,"acquired":true,"shares":33622,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects the grant of restricted stock units (\"RSUs\"). Each RSU represents a contingent right to receive one share of the Issuer's common stock, vesting in three equal annual installments beginning on February 10, 2027, the first anniversary of the grant, subject to the Reporting Person's continued service with the Issuer."}],"balance_after":190762,"source":{"system":"sec-edgar","filing":"0002014639-26-000004","document":"wk-form4_1770930279.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2014639/000201463926000004/wk-form4_1770930279.xml","form_type":"4"}}]}